November 28, 2017 / 10:08 PM / 20 days ago

BRIEF-Tetra Bio-Pharma Accelerates Submission Of NDA To FDA & Expects To Commercialize Dronabinol XL Tablet Ahead Of Schedule(1) In The U.S.

Nov 28 (Reuters) - Tetra Bio Pharma Inc:

* TETRA BIO-PHARMA ACCELERATES SUBMISSION OF NEW DRUG APPLICATION TO FDA & EXPECTS TO COMMERCIALIZE DRONABINOL XL TABLET AHEAD OF SCHEDULE(1) IN THE U.S. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below